Cargando…
Intranasal COVID-19 vaccines: From bench to bed
Currently licensed COVID-19 vaccines are all designed for intramuscular (IM) immunization. However, vaccination today failed to prevent the virus infection through the upper respiratory tract, which is partially due to the absence of mucosal immunity activation. Despite the emerging severe acute res...
Autores principales: | Alu, Aqu, Chen, Li, Lei, Hong, Wei, Yuquan, Tian, Xiaohe, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785603/ https://www.ncbi.nlm.nih.gov/pubmed/35085851 http://dx.doi.org/10.1016/j.ebiom.2022.103841 |
Ejemplares similares
-
BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022) -
The modulatory effect of high salt on immune cells and related diseases
por: Li, Xian, et al.
Publicado: (2022) -
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
por: Ni, Yanghong, et al.
Publicado: (2021) -
The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020) -
cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)